Cardio Diagnostics Holdings, Inc. held its annual stockholders' meeting on November 15, 2024, where shareholders voted on four proposals, including the election of directors and approval of a reverse stock split, with 55.51% of eligible shares represented. Key outcomes included the election of seven directors, approval of a reverse stock split, and ratification of the independent accounting firm for 2024.